and DXA scans to automatically analyze X-rays and generate reports for clinicians and patients. This approach offers high accuracy, with an AUC of 0.94, making it a reliable tool for recommending further tests and treatment opportunities. The software seamlessly integrates with existing IT systems (e.g., PACS), ensuring instant visibility of AI results. By facilitating early screening and ongoing monitoring, Osteo Signal contributes to improved patient outcomes and supports the long-term management of osteoporosis.